Inhibition/NN
of/IN
NF-kappa/NN
B/NN
activation/NN
in/IN
human/JJ
T-cell/NN
lines/NNS
by/IN
anetholdithiolthione/NN
./.

Nuclear/JJ
factor/NN
(/(
NF/NN
)/)
-kappa/NN
B/NN
is/VBZ
a/DT
redox/NN
sensitive/JJ
cytosolic/JJ
transcription/NN
factor/NN
./.
=====
Redox/NN
regulation/NN
of/IN
NF-kappa/NN
B/NN
has/VBZ
been/VBN
implicated/VBN
in/IN
the/DT
activation/NN
of/IN
the/DT
human/JJ
immuno-deficiency/NN
virus/NN
(/(
HIV/NN
)/)
./.
=====
Therefore/RB
,/,
inhibition/NN
of/IN
NF-kappa/NN
B/NN
activation/NN
may/MD
be/VB
an/DT
effective/JJ
strategy/NN
for/IN
acquired/VBN
immunodeficiency/NN
syndrome/NN
therapy/NN
./.
=====
Anetholdithiolthione/NN
(/(
ADT/NN
,/,
5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione/NN
)/)
is/VBZ
an/DT
antioxidant/NN
which/WDT
has/VBZ
been/VBN
used/VBN
to/TO
protect/VB
against/IN
acetaminophen-/NN
and/CC
CCl4-induced/JJ
hepatotoxicity/NN
,/,
lipid/NN
peroxidation/NN
,/,
radiation/NN
injury/NN
,/,
and/CC
also/RB
has/VBZ
been/VBN
used/VBN
clinically/RB
as/IN
an/DT
anti-choleretic/JJ
agent/NN
./.
=====
The/DT
present/JJ
study/NN
examined/VBD
the/DT
effect/NN
of/IN
ADT/NN
pretreatment/NN
on/IN
NF-kappa/NN
B/NN
activation/NN
in/IN
response/NN
to/TO
a/DT
variety/NN
of/IN
stimuli/NNS
such/JJ
as/IN
H2O2/NN
,/,
phorbol/NN
myristate/NN
acetate/NN
(/(
PMA/NN
)/)
or/CC
tumor/NN
necrosis/NN
factor/NN
alpha/NN
(/(
TNF/NN
alpha/NN
)/)
./.
=====
PMA/NN
and/CC
TNF/NN
alpha/NN
induced/JJ
activation/NN
of/IN
(/(
NF/NN
)/)
-kappa/NN
B/NN
in/IN
human/JJ
Jurkat/NN
T-cells/NNS
was/VBD
partially/RB
inhibited/VBN
by/IN
ADT/NN
(/(
0.1/CD
mM/NN
)/)
pretreatment/NN
./.
=====
ADT/NN
(/(
0.1/CD
mM/NN
)/)
also/RB
inhibited/VBD
H2O2/NN
induced/JJ
activation/NN
of/IN
the/DT
transcription/NN
factor/NN
in/IN
the/DT
peroxide/NN
sensitive/JJ
human/JJ
Wurzburg/NN
T-cells/NNS
./.
=====
Furthermore/RB
,/,
ADT/NN
treated/JJ
Wurzburg/NN
cells/NNS
had/VBD
significantly/RB
higher/JJR
glutathione/NN
levels/NNS
as/IN
compared/VBN
with/IN
untreated/JJ
cells/NNS
./.
=====
H2O2/NN
induced/JJ
lipid/NN
peroxidation/NN
in/IN
Wurzburg/NN
cells/NNS
was/VBD
remarkably/RB
inhibited/VBN
by/IN
ADT/NN
pretreatment/NN
./.
=====
ADT/NN
,/,
a/DT
pro-glutathione/NN
antioxidant/NN
,/,
was/VBD
observed/VBN
to/TO
be/VB
capable/JJ
of/IN
modulating/VBG
NF-kappa/NN
B/NN
activation/NN
./.